한글목차

세계 포토페레시스 시장은 폐쇄성 세기관지염 증후군과 재발성 급성 거부반응 시장에서 기회가 있으며, 미래성이 기대됩니다. 세계 포토페레시스 시장은 2025년부터 2031년까지 CAGR 5.7%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 자가 면역 질환의 유병률 증가, 이식편 대 숙주 질환 사례의 증가, 비침습적 치료 옵션에 대한 수요입니다.

Lucintel은 유형별로는 체외 포토페레시스가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상하고 있습니다.

용도별로는 재발성 급성 거부반응이 높은 성장세를 보일 것으로 예상됩니다.

지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.

150페이지가 넘는 종합적인 보고서에서 비즈니스 의사결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 다음은 몇 가지 인사이트를 담은 샘플 다이어그램입니다.

포토페레시스 시장의 새로운 동향

포토페레시스 시장은 기술 혁신, 환자 수요 증가, 진화하는 헬스케어 시스템으로 인해 주요 트렌드가 나타나면서 큰 변화의 시기를 맞이하고 있습니다. 이러한 추세는 전 세계 포토페레시스 치료의 전망을 재구성하는 데 도움이 되고 있습니다.

• 포토페레시스 장치의 기술적 진보 : 보다 컴팩트하고, 자동화되고, 환자 친화적인 포토페레시스 장치의 개발로 치료 결과가 향상되고 있습니다. 이러한 발전은 치료 시간을 단축하고, 안전성을 높이며, 전반적인 환자 경험을 개선하고 있습니다. 기술이 계속 발전함에 따라 포토페레시스는 더욱 친숙하고 효율적인 치료법이 될 것으로 기대됩니다.
• 암 및 자가면역질환에 대한 채택 확대 : 포토페레시스는 CTCL과 같은 암과 GVHD와 같은 자가면역질환에 대한 효과적인 치료법으로 인정받고 있습니다. 이러한 추세는 전 세계 병원과 클리닉에서 포토페레시스 채택을 확대하여 환자 치료 결과를 개선하고 시장 성장을 견인하고 있습니다.
• 맞춤형 치료 옵션에 대한 관심 : 맞춤형 의료가 증가함에 따라, 특히 암 치료에서 포토페레시스는 환자 개개인의 필요에 따라 맞춤화되어 가고 있습니다. 이러한 추세는 포토페레시스 치료의 정확성과 효능을 높이는 데 초점을 맞추고 있으며, 각 환자의 고유한 상태와 치료 요건에 부합하도록 보장하고 있습니다.
• 외래 포토페레시스 치료로의 전환 : 점점 더 많은 병원과 클리닉이 외래에서 포토페레시스 치료를 제공하고 있으며, 이는 환자들에게 더 편리해졌습니다. 이러한 변화는 보다 효율적인 치료를 가능하게 하고, 입원 기간 및 관련 비용을 절감하며, 환자 만족도를 향상시키는 포토페레시스 장비의 기술 발전으로 인해 이루어지고 있습니다.
• 신흥시장 진출 : 포토페레시스 시장은 선진 의료에 대한 수요가 증가하고 있는 신흥국가로 확대되고 있습니다. 인도, 중국 등의 국가에서는 만성질환 치료에 포토페레시스를 도입하고 있으며, 이는 이들 지역 시장에 큰 성장 기회를 제공하고 있습니다.

이러한 새로운 트렌드는 기술 발전, 접근성 향상, 치료 정확도 향상을 촉진하며 포토페레시스 시장을 재편하고 있습니다. 시장이 성장함에 따라, 특히 신흥 경제권에서 개인화되고, 효율적이며, 외래 환자 친화적인 포토페레시스 옵션에 대한 수요가 증가하여 세계 시장의 상당한 성장에 기여할 것으로 예상됩니다.

포토페레시스 시장의 최근 동향

포토페레시스 시장은 기술, 임상 적용, 환자 치료의 괄목할 만한 발전과 함께 최근 주목할 만한 성장세를 보이고 있습니다. 이러한 발전은 특히 암 및 자가면역질환 치료와 같은 다양한 증상에 대한 효과적인 치료법으로 포토페레시스의 채택 확대에 기여하고 있습니다.

• 새로운 포토페레시스 시스템의 FDA 승인 미국 FDA는 최근 안전성이 개선되고 보다 효율적인 치료를 제공하는 새로운 포토페레시스 장치를 승인했습니다. 이러한 승인은 특히 혈액암 및 자가면역질환 치료에서 포토페레시스의 보급을 촉진하고 시장을 더욱 확대할 것으로 기대됩니다.
• 포토페레시스 연구를 위한 새로운 파트너십 : 포토페레시스 연구를 촉진하기 위해 학술 기관과 헬스케어 기업 간의 전략적 제휴가 증가하고 있습니다. 이러한 협력은 보다 효과적이고 정확한 치료법 개발에 초점을 맞추고 있으며, 표준 치료 요법에 포토페레시스의 통합을 가속화하는 데 도움이 되고 있습니다.
• 고형암에 대한 포토페레시스 개발 : 포토페레시스는 고형암 치료에도 적용되고 있으며, 기존의 혈액암에 대한 적용에서 크게 변화하고 있습니다. 초기 단계의 임상시험에서 유망한 결과를 얻었으며, 포토페레시스의 사용이 보다 광범위한 암 치료로 확대될 가능성이 있습니다.
• 외래 진료에서의 포토페레시스의 성장 : 외래에서의 포토페레시스 치료는 기술의 발전과 함께 점점 더 보편화되고 있습니다. 휴대가 간편하고 효율적인 장비의 개발로 환자들은 외래에서 치료를 받을 수 있게 되어 편의성을 높이고 의료비용을 절감할 수 있게 되었습니다. 이러한 추세는 전 세계적으로 포토페레시스 치료의 채택을 촉진할 것으로 예상됩니다.
• 포토페레시스 업체들의 국제적 진출 : 포토페레시스 장비의 주요 제조업체들은 국제 시장, 특히 아시아와 라틴아메리카에서 시장 입지를 확대하고 있습니다. 이들 지역의 의료 시스템이 발전함에 따라 포토페레시스를 포함한 고급 치료에 대한 수요가 증가하고 있으며, 이는 이들 지역의 시장 성장의 원동력이 되고 있습니다.

포토페레시스 시장의 최근 동향은 특히 기술 발전, 임상 연구, 광범위한 접근성을 통해 포토페레시스의 도입과 효능을 높이고 있습니다. 이러한 변화는 포토페레시스를 종양학 및 자가면역질환 치료에서 중요한 치료 옵션으로 자리매김하며 시장의 지속적인 성장과 혁신에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 세계의 포토페레시스 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 포토페레시스 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 포토페레시스 시장 : 유형별
  • 체외광분반술
  • 백혈구성분채집술
  • 혈장분리교환술
  • 기타
• 세계의 포토페레시스 시장 : 용도별
  • 폐쇄성 세기관지염 증후군
  • 재발성 급성 거부반응
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2019-2031년)

• 세계의 포토페레시스 시장 : 지역별
• 북미의 포토페레시스 시장
• 유럽의 포토페레시스 시장
• 아시아태평양의 포토페레시스 시장
• 기타 지역의 포토페레시스 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 포토페레시스 시장의 성장 기회 : 유형별
  • 세계의 포토페레시스 시장의 성장 기회 : 용도별
  • 세계의 포토페레시스 시장의 성장 기회 : 지역별
• 세계의 포토페레시스 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 포토페레시스 시장 능력 확대
  • 세계의 포토페레시스 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Haemonetics
• Fresenius Kabi
• Terumo
• Macopharma
• Mallinckrodt Pharmaceuticals

영문목차

The future of the global photopheresis market looks promising with opportunities in the bronchiolitis obliterans syndrome and recurrent acute rejection markets. The global photopheresis market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of autoimmune disease, increasing cases of graft-versus-host disease, and demand for non-invasive treatment options.

Lucintel forecasts that, within the type category, extracorporeal photopheresis is expected to witness the highest growth over the forecast period.

Within the application category, recurrent acute rejection is expected to witness higher growth.

In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Photopheresis Market

The photopheresis market is undergoing significant transformation, with key trends emerging due to innovations in technology, increasing patient demand, and evolving healthcare systems. These trends are helping to reshape the landscape of photopheresis treatment across the world.

• Technological Advancements in Photopheresis Devices: The development of more compact, automated, and patient-friendly photopheresis devices is improving treatment outcomes. These advancements reduce treatment times, increase safety, and enhance the overall patient experience. As the technology continues to evolve, it is expected to make photopheresis more accessible and efficient.
• Growing Adoption for Cancer and Autoimmune Diseases: Photopheresis is being increasingly recognized as an effective treatment for cancers like CTCL and autoimmune diseases such as GVHD. This trend is leading to greater adoption of photopheresis therapies in hospitals and clinics worldwide, improving patient outcomes and expanding market growth.
• Focus on Personalized Treatment Options: With personalized medicine on the rise, photopheresis is being tailored to individual patient needs, particularly in cancer care. This trend focuses on enhancing the precision and efficacy of photopheresis treatments, ensuring that they are suited to each patient's unique condition and treatment requirements.
• Shift toward Outpatient Photopheresis Procedures: Hospitals and clinics are increasingly offering outpatient photopheresis treatments, making it more convenient for patients. This shift is driven by technological advancements in photopheresis devices that enable more efficient treatments, reducing hospital stays and associated costs, and improving patient satisfaction.
• Expansion into Emerging Markets: The photopheresis market is expanding into emerging economies, where there is a growing demand for advanced medical treatments. Countries such as India and China are seeing increased adoption of photopheresis for treating chronic diseases, presenting a significant growth opportunity for the market in these regions.

These emerging trends are reshaping the photopheresis market by driving technological advancements, improving accessibility, and enhancing the precision of treatments. As the market grows, particularly in emerging economies, the demand for personalized, efficient, and outpatient-friendly photopheresis options is expected to increase, contributing to significant growth in the global market.

Recent Developments in the Photopheresis Market

The photopheresis market has seen notable developments in recent years, with significant advancements in technology, clinical applications, and patient care. These developments have contributed to the growing adoption of photopheresis as an effective treatment for a variety of conditions, particularly in the treatment of cancer and autoimmune diseases.

• FDA Approval of New Photopheresis Systems: The U.S. FDA has recently approved new photopheresis devices that offer improved safety features and more efficient processing. These approvals are driving the widespread adoption of photopheresis, particularly in the treatment of blood cancers and autoimmune conditions, which is expanding the market further.
• Emerging Partnerships for Photopheresis Research: There has been an increase in strategic partnerships between academic institutions and healthcare companies to advance photopheresis research. These collaborations are focused on developing more effective and precise treatments, helping to accelerate the integration of photopheresis into standard treatment regimens.
• Development of Photopheresis for Solid Tumors: Photopheresis is being explored for the treatment of solid tumors, a significant shift from its traditional use in blood cancers. Early-stage clinical trials have shown promising results, potentially expanding the use of photopheresis to a broader range of cancer treatments.
• Growth of Photopheresis in Outpatient Clinics: Outpatient photopheresis treatments are becoming more common as technology improves. With the development of more portable and efficient devices, patients can undergo treatment in outpatient settings, improving convenience and reducing healthcare costs. This trend is expected to drive the adoption of photopheresis therapy worldwide.
• International Expansion of Photopheresis Providers: Several leading photopheresis device manufacturers are expanding their market presence in international markets, particularly in Asia and Latin America. As healthcare systems in these regions evolve, there is increased demand for advanced treatments, including photopheresis, which is driving market growth in these areas.

Recent developments in the photopheresis market are enhancing its adoption and effectiveness, particularly through technological advancements, clinical research, and broader accessibility. These changes are positioning photopheresis as a vital treatment option in oncology and autoimmune disease care, contributing to the market's ongoing growth and innovation.

Strategic Growth Opportunities in the Photopheresis Market

The photopheresis market offers several growth opportunities across key applications, particularly in the treatment of cancers, autoimmune disorders, and other chronic conditions. As technology improves and adoption increases, new markets and applications are emerging, offering significant growth potential.

• Cancer Treatment Applications: Photopheresis is increasingly being adopted in the treatment of cancers, especially cutaneous T-cell lymphoma and graft-versus-host disease. The continued development of photopheresis technologies for cancer therapies presents a key growth opportunity, expanding treatment options for patients and increasing market demand.
• Autoimmune Disorder Treatment: Photopheresis has proven effective in treating autoimmune disorders like GVHD and scleroderma. As awareness of its efficacy grows, there is significant potential for expanded use in autoimmune disease management, particularly in regions with high prevalence, such as North America and Europe.
• Pediatric Applications: Photopheresis is gaining traction in pediatric applications for treating autoimmune diseases and certain cancers. As treatment regimens become more personalized and less invasive, photopheresis holds promise in offering children more manageable treatment options with fewer side effects.
• Outpatient Treatment Opportunities: As photopheresis devices become more compact and efficient, the potential for outpatient treatments increases. This development offers a strategic growth opportunity, allowing healthcare providers to offer more flexible and cost-effective treatment options for patients, improving patient satisfaction, and expanding market reach.
• Expanding Markets in Developing Regions: Emerging markets, such as India and China, are increasingly adopting advanced medical technologies like photopheresis. The growing healthcare infrastructure in these regions presents significant growth opportunities for photopheresis providers looking to expand their market presence and serve a growing patient base.

The photopheresis market is poised for substantial growth due to key strategic opportunities in cancer treatment, autoimmune disorders, and pediatric care. As technology advances and accessibility increases, particularly in outpatient settings and emerging markets, these growth areas will drive the market's expansion and enhance its role in global healthcare.

Photopheresis Market Driver and Challenges

The photopheresis market is influenced by various technological, economic, and regulatory drivers and challenges. These factors are shaping the growth of the market by influencing the adoption of photopheresis technology, its effectiveness, and its accessibility across different regions.

The factors responsible for driving the photopheresis market include:

1. Technological Advancements in Photopheresis Devices: The continuous development of more compact, efficient, and automated photopheresis devices is a major driver in the market. These advancements improve patient comfort, reduce treatment times, and increase the overall efficiency of photopheresis therapies, driving greater adoption in clinical settings.

2. Rising Incidence of Autoimmune Diseases and Cancers: An increase in the incidence of autoimmune diseases and cancers, especially hematologic malignancies, is driving the demand for photopheresis treatments. As these conditions become more prevalent, the need for effective treatment options like photopheresis grows, contributing to market expansion.

3. Government Support and Reimbursement Policies: Government initiatives and favorable reimbursement policies are encouraging healthcare providers to adopt photopheresis treatments. This support, especially in developed markets, ensures that photopheresis becomes more accessible to patients, fueling its market growth.

4. Growing Patient Preference for Non-invasive Treatments: Patients increasingly prefer non-invasive treatments like photopheresis over traditional methods such as chemotherapy or surgery. The rising demand for less invasive treatment options is a significant driver for photopheresis adoption, particularly for chronic conditions like autoimmune diseases.

5. Expanding Healthcare Infrastructure in Emerging Markets: Improving healthcare infrastructure in developing regions is opening new opportunities for photopheresis treatment. As hospitals and clinics in these regions invest in advanced technologies, the demand for photopheresis is expected to increase, contributing to market growth.

Challenges in the photopheresis market are:

1. High Treatment Costs: The high cost of photopheresis treatments, including the expense of devices and specialized procedures, remains a significant challenge. These costs can limit the adoption of photopheresis in lower-income regions and may hinder broader market expansion.

2. Efficacy Concerns and Limited Indications: Despite its effectiveness in certain conditions, the efficacy of photopheresis in treating other diseases is still being studied. Limited indications for use in non-cancerous conditions may slow the growth of the market, as more evidence is needed to justify its broader application.

3. Regulatory Hurdles and Approval Delays: The regulatory approval process for new photopheresis devices can be lengthy and complex, delaying market entry. Stringent regulations in different regions may slow the adoption of new technologies, which can impact market growth and innovation.

The major drivers of the photopheresis market include technological advancements, rising disease prevalence, and supportive government policies. However, challenges such as high treatment costs, limited indications, and regulatory hurdles must be overcome for the market to reach its full potential. Addressing these challenges will be key to sustaining growth in the photopheresis market.

List of Photopheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies photopheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the photopheresis companies profiled in this report include-

• Haemonetics
• Fresenius Kabi
• Terumo
• Macopharma
• Mallinckrodt Pharmaceuticals

Photopheresis Market by Segment

The study includes a forecast for the global photopheresis market by type, application, and region.

Photopheresis Market by Type [Value from 2019 to 2031]:

• Extracorporeal Photopheresis
• Leukapheresis
• Plasmapheresis
• Others

Photopheresis Market by Application [Value from 2019 to 2031]:

• Bronchiolitis Obliterans Syndrome
• Recurrent Acute Rejection
• Others

Photopheresis Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Photopheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. It highlights recent developments by major photopheresis producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., photopheresis technology is increasingly being used for treating conditions like cutaneous T-cell lymphoma (CTCL) and graft-versus-host disease (GVHD). Key players in the market are focusing on improving the efficiency and safety of photopheresis machines, as well as enhancing patient comfort during treatment.
• China: China is witnessing a surge in demand for photopheresis treatments, particularly for cancer and autoimmune diseases. The government's focus on improving healthcare infrastructure is driving the adoption of photopheresis technologies, and local manufacturers are increasingly involved in the production of photopheresis devices to meet the rising demand.
• Germany: Germany remains at the forefront of photopheresis technology in Europe. Research institutions in the country are developing more advanced systems for photopheresis, particularly targeting hematologic malignancies. The German healthcare system continues to support the integration of photopheresis as a treatment for various blood disorders, pushing forward innovation in the market.
• India: India is seeing rapid adoption of photopheresis in the treatment of conditions like skin diseases and certain types of cancers. Indian hospitals are increasingly investing in photopheresis devices, driven by a growing demand for advanced cancer and autoimmune treatments. This development is enhancing the treatment landscape in the country.
• Japan: In Japan, photopheresis is gaining popularity for treating conditions such as lymphoma and autoimmune disorders. Japan's focus on advancing medical technologies is boosting the market, with local companies developing innovative photopheresis systems that emphasize patient comfort, treatment efficiency, and safety.

Features of the Global Photopheresis Market

Market Size Estimates: Photopheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Photopheresis market size by type, application, and region in terms of value ($B).

Regional Analysis: Photopheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the photopheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the photopheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the photopheresis market by type (extracorporeal photopheresis, leukapheresis, plasmapheresis, and others), application (bronchiolitis obliterans syndrome, recurrent acute rejection, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Photopheresis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Photopheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Photopheresis Market by Type
  • 3.3.1: Extracorporeal Photopheresis
  • 3.3.2: Leukapheresis
  • 3.3.3: Plasmapheresis
  • 3.3.4: Others
• 3.4: Global Photopheresis Market by Application
  • 3.4.1: Bronchiolitis Obliterans Syndrome
  • 3.4.2: Recurrent Acute Rejection
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Photopheresis Market by Region
• 4.2: North American Photopheresis Market
  • 4.2.1: North American Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.2.2: North American Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.3: European Photopheresis Market
  • 4.3.1: European Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.3.2: European Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.4: APAC Photopheresis Market
  • 4.4.1: APAC Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.4.2: APAC Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others
• 4.5: ROW Photopheresis Market
  • 4.5.1: ROW Market by Type: Extracorporeal Photopheresis, Leukapheresis, Plasmapheresis , and Others
  • 4.5.2: ROW Market by Application: Bronchiolitis Obliterans Syndrome, Recurrent Acute Rejection, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Photopheresis Market by Type
  • 6.1.2: Growth Opportunities for the Global Photopheresis Market by Application
  • 6.1.3: Growth Opportunities for the Global Photopheresis Market by Region
• 6.2: Emerging Trends in the Global Photopheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Photopheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Photopheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Haemonetics
• 7.2: Fresenius Kabi
• 7.3: Terumo
• 7.4: Macopharma
• 7.5: Mallinckrodt Pharmaceuticals